People with both type 2 diabetes and chronic kidney disease face a heart health double-whammy, a new study says.

A nationwide study from Japan spanning a 14-year study period has revealed an increasing trend of overweight and obesity in ...

A recent nationwide study conducted in Japan has revealed a substantial increase in overweight and obesity prevalence among ...

Ozempic (semaglutide) may impact kidney health in certain people, especially those with diabetes. Learn more about what the ...

Yes, you can live with one kidney, whether you were born with one or later lost a kidney to disease or from being a donor.

In a mate-kidney analysis, Black race was associated with significantly increased odds of delayed graft function and graft ...

In a 24-week trial, semaglutide led to a 52% reduction in albuminuria and improved kidney health in individuals with chronic ...

Beta blockers are go-to meds for many people who've survived a heart attack, but might not be needed for patients whose ...

Patients taking semaglutide -- the active agent in Ozempic and Wegovy -- had as much as a 52% reduction in kidney damage, as measured by urine testing, researchers reported Oct. 25 in the journal ...

A new nationwide study from Japan spanning a 14 year study period has revealed an increasing trend of overweight and obesity in patients with the incident end-stage kidney disease (ESKD).